Based on these molecular observations and the present case report, we hypothesized that EPO produced by RCC cells raises the levels of circulating HSCs and the vascular endothelium-rich RCC acts as a niche that allows circulating HSCs to colonize within the tumor and initiate BM formation. The gene discussed is EPO; the disease is renal cell carcinoma.